<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00969397</url>
  </required_header>
  <id_info>
    <org_study_id>NIH-LAMMP-2009-7069</org_study_id>
    <nct_id>NCT00969397</nct_id>
  </id_info>
  <brief_title>Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks</brief_title>
  <official_title>Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researcher want to improve port wine stain (PWS) therapeutic outcome in response to laser
      therapy. The researcher want to determine whether the combined use of pulsed dye laser (PDL)
      therapy and topical tacrolimus or pimecrolimus will improve PWS therapeutic outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Both topical agents inhibit nuclear factor of activated T-cells (NFAT) which blocks the
      calcineurin/NFAT pathway inhibiting endothelial cell proliferation and angiogenesis, which
      could be very useful in preventing PWS recanalization.

      The combined use of PDL to induce PWS blood vessel injury, and topical antiangiogenic agents
      to prevent PWS blood vessel angiogenesis and recanalization after laser therapy, will improve
      PWS lesion blanching.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    We have decided not to pursue the study
  </why_stopped>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improve PWS lesion blanching.</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine whether the combined use of pulsed dye laser (PDL) therapy and topical agent will improve PWS outcome.</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Port Wine Stain</condition>
  <arm_group>
    <arm_group_label>Topical Antiangiogenic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topical Antiangiogenic Agents</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulsed Dye Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pulsed Dye Laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical Antiangiogenic</intervention_name>
    <description>Topical Antiangiogenic</description>
    <arm_group_label>Topical Antiangiogenic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed Dye Laser</intervention_name>
    <description>Pulsed Dye Laser</description>
    <arm_group_label>Pulsed Dye Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  16 years of age and older

          -  Have PWS suitable for comparison testing as determined by the study doctor

        Exclusion Criteria:

          -  Less than 16 years old

          -  Are pregnant

          -  Have skin cancer

          -  Currently taking immunosuppressive or steroids or photosensitizing drugs

          -  Current participation in any other investigational drug evaluation

          -  Concurrent use of known photosensitizing drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John S Nelson, M.D,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute University of California Irvine</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2009</study_first_submitted>
  <study_first_submitted_qc>August 31, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2009</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>J S Nelson, M.D., Ph.D.,Professor of Surgery and Biomedical Engineering</investigator_title>
  </responsible_party>
  <keyword>Birthmark</keyword>
  <keyword>PWS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Port-Wine Stain</mesh_term>
    <mesh_term>Hemangioma, Capillary</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angiogenesis Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

